Discover
Related topics
Discover the Celloger live-cell analyzers : miniaturized and powerful tools for every Biologist
Apr 5, 2024
Celloger live-cell analyzers, image and analyze your cells in real-time, inside your incubator. With its exceptional...
Cytek SpectroFlo Software Version 3.3 has been released!
Mar 25, 2024
SpectroFlo Software Version 3.3 has been released, enabling new assays with SpectroFlo Software version 3.3, including...
Mar 22, 2024
Mission Bio’s Tapestri Tool May Hold the Key to Informing Treatment Options for Multiple Myeloma.
Real-time and quantitative analysis of Macrophage Phagocytosis with RTCA eSight
Feb 23, 2024
The eSight is currently the only instrument that interrogates cell health and behavior using cellular
impedance...
Whole-slide biomarker quantitation in 82-patient NSCLC cohort study of acquired resistance to PD-(L)
Feb 7, 2024
Samples from 82 patients with NSCLC and matched pre- and post-ICI biopsies were subjected to genomic profiling and to...
Introducing The Cytek Orion: Reagent Cocktail Preparation System
Jan 29, 2024
Cytek is proud to announce the Cytek Orion reagent cocktail preparation system. The Cytek Orion system allows for...
Meet new Analytik Jena qTOWERiris series
Jan 19, 2024
Thanks to a very precise thermoblock made of silver and the use of a unique, super-fast and very accurate optical...
Small animal DXA instrument comparison and validation 2024
Jan 8, 2024
This study evaluated the performance of two relatively new peripheral bone densitometry machines, the InAlyzer and the...
Flexible multiplex panel design with new Orion Reagents
Jan 5, 2024
Orion Reagents are tailored to enable spatial biomarker quantitation rapidly, easily and with maximum flexibility....
Extracellular Vesicle Refractive Index derivation utilizing Spectral Flow Cytometry
Dec 21, 2023
In this recent publication in NANO Letters, a four laser Cytek Aurora system with enhanced small particle (ESP)...
Nov 26, 2021
The IsoLight platform’s predictive single-cell response enables quality assessments of T cell immunotherapies, as well as improved assessment of clinical response and mechanism of action in patient samples.Toxicity, low or no response, and relapse are major challenges of immune-based cancer therapies faced on both manufacturing and clinical development pathways toward success in patient outcome. Confounding factors with respect to specifications for toxicity and potentially lethal side effects in chimeric antigen receptor (CAR) T cell therapies are related to the complex functional responses of these engineered T cells. Isoplexis provides actionable potency, safety, and patient-difference metrics by assessing deep T cell functional response in patients, accelerating decisions toward clinical success downstream, and enhancing scalability
Related technologies: Functional biology
Get more info
Brand profile
Systems, which drive convergence of dynamic proteomics and single cell biology for the first time, are creating this deeper connection to accelerate curative medicines.
More info at:
https://isoplexis.com
